Stocks

Stock Market News & Analysis

Latest stock picks, earnings reports, IPOs, and equity market analysis for investors.

Nvidia Stock Slips 1.3% as Broad Market Weakness Overshadows Apple AI Deal
Stocks
Nvidia Stock Slips 1.3% as Broad Market Weakness Overshadows Apple AI Deal
Nvidia stock reversed early gains to trade down 1.3% on Tuesday, as broader market weakness offset news that Apple will
Astera Labs Stock Surges 253% to $60B Valuation: Overvaluation Risks Loom
Stocks
Astera Labs Stock Surges 253% to $60B Valuation: Overvaluation Risks Loom
Astera Labs stock has soared 253% to a $60B valuation, driven by the data center boom. However, a forward P/E of 153 and
Rocket Lab Stock Drops 25% Into Local Bear Market: Key Support at $100
Stocks
Rocket Lab Stock Drops 25% Into Local Bear Market: Key Support at $100
Rocket Lab stock has entered a local bear market, dropping 25% from its 2025 high to $113. Technicals point to a possibl
Intuit Stock Plunges 62% in 2025, Becomes Nasdaq 100's Worst Performer: A Contrarian Play?
Stocks
Intuit Stock Plunges 62% in 2025, Becomes Nasdaq 100's Worst Performer: A Contrarian Play?
Intuit stock has fallen 62% in 2025, the worst in the Nasdaq 100. Despite slowing growth and Mailchimp struggles, revenu
Applied Digital Soars 10% on $5.2B AI Lease; Analysts Boost Targets to $90
Stocks
Applied Digital Soars 10% on $5.2B AI Lease; Analysts Boost Targets to $90
Applied Digital shares surged over 10% after announcing a $5.2B AI data center lease with a hyperscaler. Analysts raised
AstraZeneca Obesity Pill Shows 11.8% Weight Loss; Analysts See Upside Beyond Consensus
Stocks
AstraZeneca Obesity Pill Shows 11.8% Weight Loss; Analysts See Upside Beyond Consensus
AstraZeneca's experimental obesity pill elecoglipron helped patients lose up to 11.8% body weight in a mid-stage trial.
GSK's $10.6B Nuvalent Deal Fails to Rally Stock as Investors Eye Regulatory Hurdles
Stocks
GSK's $10.6B Nuvalent Deal Fails to Rally Stock as Investors Eye Regulatory Hurdles
GSK shares dropped 3% after announcing a $10.6B Nuvalent takeover. The deal strengthens its lung cancer pipeline but inv
SpaceX IPO Oversubscribed 2x Ahead of June 11 Pricing: Valuation Debate Intensifies
Stocks
SpaceX IPO Oversubscribed 2x Ahead of June 11 Pricing: Valuation Debate Intensifies
SpaceX's IPO is oversubscribed 2x with $150B in orders, but valuation concerns persist as Morningstar estimates fair val
SpaceX IPO Fuels Global Rally; Asian Proxy Stocks Surge as Direct Access Limited
Stocks
SpaceX IPO Fuels Global Rally; Asian Proxy Stocks Surge as Direct Access Limited
SpaceX's upcoming IPO, targeting a $1.8 trillion valuation, has ignited a global rally. Asian investors, facing access r
Samsung Rebounds 5% After Circuit Breaker Crash: Is This the Buy of the Year?
Stocks
Samsung Rebounds 5% After Circuit Breaker Crash: Is This the Buy of the Year?
Samsung shares rebounded 5% on Tuesday after a historic 10.2% plunge triggered South Korea's KOSPI circuit breaker. The
Perplexity CEO Reaffirms 2028 IPO Timeline Amid Anthropic, OpenAI Filing Wave
Stocks
Perplexity CEO Reaffirms 2028 IPO Timeline Amid Anthropic, OpenAI Filing Wave
Perplexity CEO Aravind Srinivas reaffirms the AI search startup's 2028 IPO timeline, even as Anthropic and OpenAI move c
Foreign Capital Exodus from South Korea: Why Long-Term Investors Should Buy the Dip
Stocks
Foreign Capital Exodus from South Korea: Why Long-Term Investors Should Buy the Dip
Foreign investors have pulled $62 billion from South Korean stocks, but the selloff is driven by forced rebalancing, not